Longitudinal Point Prevalence Survey of Antimicrobial Consumption in Russian Hospitals: Results of the Global-PPS Project
Authors:
- Svetlana RachinaSvetlana Rachina
- Yuliya BelkovaYBYuliya Belkova
- Roman KozlovRoman Kozlov
- Ann VersportenAVAnn Versporten
- Ines PauwelsIPInes Pauwels
- Herman GoossensHGHerman Goossens
- Elena BochanovaEBElena Bochanova
- Olga DomanskayaODOlga Domanskaya
- Elena ElokhinaEEElena Elokhina
- Ludmila EzhovaLELudmila Ezhova
- Vladimir MishchenkoVMVladimir Mishchenko
- Oksana NiONOksana Ni
Open Access
- 25 July 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (8) , 446
Abstract
Antimicrobial resistance is one of the key issues limiting the successful treatment of infectious diseases and associated with adverse medical, social and economic consequences on a global scale. The present study aims to evaluate antimicrobials prescribing patterns and assess progress in quality indicators in Russian multidisciplinary hospitals using three repetitive point prevalence studies (PPSs) over 4 years (Global-PPS 2015, 2017 and 2018). Out of 13,595 patients from 21 hospitals surveyed over the three time points, 3542 (26.14%) received antimicrobials, predominantly third-generation cephalosporins (44.7% in 2015, 34.1% in 2017 and 41.8% in 2018). Compliance with the hospital antibiotic guidelines was 74.8%, 66.8% and 74.3%, respectively. Indication for treatment was recorded in 72.6%, 84.1% and 82.6%, while stop/review date was documented only in 40.5%, 46.5% and 61.1% of cases. Perioperative antibiotic prophylaxis exceeded 1 day in 92%, 84% and 81% of cases. Targeted therapy rate at all time points did not exceed 15.1%, treatment based on the biomarkers rate—19.9%. For the part of PPS-2017 and 2018 analyzed in dynamics, no prominent trends were noted. The results of the project provide the basis for the development of appropriate antimicrobial stewardship programs tailored according to local practices for each hospital in the project.Keywords
Funding Information
- bioMérieux (unrestricted grant given annually)
This publication has 18 references indexed in Scilit:
- Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”Clinical Microbiology and Antimicrobial Chemotherapy, 2019
- Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”Clinical Microbiology and Antimicrobial Chemotherapy, 2019
- Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”Clinical Microbiology and Antimicrobial Chemotherapy, 2019
- Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence surveyThe Lancet Global Health, 2018
- Antimicrobial resistance: one world, one fight!Antimicrobial Resistance & Infection Control, 2015
- European Surveillance of Antimicrobial Consumption (ESAC)Drugs, 2011
- The European Surveillance of Antimicrobial Consumption (ESAC) Point‐Prevalence Survey of Antibacterial Use in 20 European Hospitals in 2006Clinical Infectious Diseases, 2009
- Clinical and economic burden of antimicrobial resistanceExpert Review of Anti-infective Therapy, 2008
- The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care CostsClinical Infectious Diseases, 2006
- Appropriate antibiotic use and why it is important: the challenges of bacterial resistanceThe Pediatric Infectious Disease Journal, 2003